A
Adaptimmune Therapeutics plc D
D
ADAP
0.27970
USD
0.00
(1.05%)
مغلق
حجم التداول
11,452
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
74,134,930
الأخبار المقالات
العنوان: Adaptimmune Therapeutics plc
القطاع: Healthcare
الصناعة: Biotechnology
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.